Prosecution Insights
Last updated: October 02, 2026

Seoul National University Hospital

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

19 pending office actions • 12 art units • 18 examiners • 0 of 19 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days

Portfolio Summary

19
Total Pending OAs
10
Non-Final OAs
9
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (2)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

15
Hard (79%)
4
Medium (21%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only2 (11%)
§101 + other7 (37%)
§103 only3 (16%)
Double-patenting + other1 (5%)
Multi-statute (no §101)6 (32%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
37% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
2
Semiconductors
11% of docket
6
Mechanical / Eng
32% of docket
4
Business / Other
21% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

190 h
Manual time on pending OAs
38 h
Time saved (low, 20%)
66 h
Time saved (mid, 35%)
1.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WESTFALL, SARAH ANN 2 0.0% +0.0%
LYNCH, ROBERT A 1 80.3% +12.9%
RABAGLIA, BRIDGET ELIZABETH 1 68.5% +15.9%
JACOB, OOMMEN 1 79.1% +17.5%
BRYANT, MICHAEL CASEY 1 78.5% +16.9%
ANTHONY, MARIA CATHERINE 1 69.3% +30.0%
ROZANSKI, GRACE NMN 1 60.5% +20.7%
DETWEILER, JAMES M 1 38.8% +43.5%
TRAN, THIEN JASON 1 74.7% +21.4%
GARTLAND, SCOTT D 1 10.9% +12.2%

Hard Cases (15)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18251949 Smart Hospital Bed Operating System and Method using Big Data GARTLAND, SCOTT D 79d overdue
18287018 SYSTEM AND METHOD FOR ELECTROCARDIOGRAM IMAGE-BASED PATIENT EVALUATION TRAN, THIEN JASON 4d overdue
18700053 CUSTOMIZED ADVERTISEMENT SYSTEM AND METHOD LINKED WITH MEDICAL INFORMATION ANALYSIS SERVICE DETWEILER, JAMES M 2d overdue
17926653 METHOD AND SYSTEM FOR PREDICTING NEEDS OF PATIENT FOR HOSPITAL RESOURCES JACKSON, JORDAN L 9d
18233783 METHOD FOR TREATING CANCER EXPRESSING SPARC NIEBAUER, RONALD T 70d
18851305 VASCULAR CLIP FOR BLOOD FLOW CONTROL LYNCH, ROBERT A —
19123848 CHEST TUBE INSERTER FOR CHEST TUBE INSERTION AND DRUG INJECTION, AND KIT INCLUDING SAME RABAGLIA, BRIDGET ELIZABETH —
18995819 BRAIN MRI ANALYSIS METHOD AND DEVICE USING NEURAL NETWORK JACOB, OOMMEN —

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18251949 Smart Hospital Bed Operating System and Method using Big Data GARTLAND, SCOTT D 79d overdue
18287018 SYSTEM AND METHOD FOR ELECTROCARDIOGRAM IMAGE-BASED PATIENT EVALUATION TRAN, THIEN JASON 4d overdue
18700053 CUSTOMIZED ADVERTISEMENT SYSTEM AND METHOD LINKED WITH MEDICAL INFORMATION ANALYSIS SERVICE DETWEILER, JAMES M 2d overdue
18851305 VASCULAR CLIP FOR BLOOD FLOW CONTROL LYNCH, ROBERT A —
19123848 CHEST TUBE INSERTER FOR CHEST TUBE INSERTION AND DRUG INJECTION, AND KIT INCLUDING SAME RABAGLIA, BRIDGET ELIZABETH —
18995819 BRAIN MRI ANALYSIS METHOD AND DEVICE USING NEURAL NETWORK JACOB, OOMMEN —
18992923 SIDE-LYING BED FOR X-RAY IMAGING BRYANT, MICHAEL CASEY —
18856562 SMART TERMINAL FOR ACQUIRING MEDICAL INFORMATION RELATED TO ELECTROCARDIOGRAPHIC AND AUDITORY ASPECTS ANTHONY, MARIA CATHERINE —

Top Art Units

Art UnitApps
1658 3
3792 2
3771 1
2884 1
3791 1
3621 1
3685 1
1653 1
1651 1
1631 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18851305 VASCULAR CLIP FOR BLOOD FLOW CONTROL LYNCH, ROBERT A — §102§103 Non-Final OA — Pending May 28, 2025
19123848 CHEST TUBE INSERTER FOR CHEST TUBE INSERTION AND DRUG INJECTION, AND KIT INCLUDING SAME RABAGLIA, BRIDGET ELIZABETH 3771 §102§103 Non-Final OA — Pending Apr 24, 2025
18995819 BRAIN MRI ANALYSIS METHOD AND DEVICE USING NEURAL NETWORK JACOB, OOMMEN 3792 §101§103 Non-Final OA — Pending Jan 16, 2025
18992923 SIDE-LYING BED FOR X-RAY IMAGING BRYANT, MICHAEL CASEY 2884 §103§112 Non-Final OA — Pending Jan 09, 2025
18879387 APPARATUS AND METHOD FOR EVALUATING CEREBRAL AUTOREGULATION WESTFALL, SARAH ANN — §101§102§103§112 Non-Final OA — Pending Dec 27, 2024
18715680 BRAIN WATER MONITORING METHOD AND APPARATUS BASED ON NEAR-INFRARED SPECTROSCOPY WESTFALL, SARAH ANN — §101§102§103§112 Non-Final OA — Pending Nov 20, 2024
18856562 SMART TERMINAL FOR ACQUIRING MEDICAL INFORMATION RELATED TO ELECTROCARDIOGRAPHIC AND AUDITORY ASPECTS ANTHONY, MARIA CATHERINE — §102§103 Non-Final OA — Pending Oct 11, 2024
18725406 METHOD AND DEVICE FOR ESTIMATING WALKING SPEED ROZANSKI, GRACE NMN 3791 §101§103 Final Rejection — Pending Jun 28, 2024
18700053 CUSTOMIZED ADVERTISEMENT SYSTEM AND METHOD LINKED WITH MEDICAL INFORMATION ANALYSIS SERVICE DETWEILER, JAMES M 3621 §101 Final Rejection 2d overdue Pending May 13, 2024
18287018 SYSTEM AND METHOD FOR ELECTROCARDIOGRAM IMAGE-BASED PATIENT EVALUATION TRAN, THIEN JASON 3792 §101§103 Final Rejection 4d overdue Pending May 08, 2024
18251949 Smart Hospital Bed Operating System and Method using Big Data GARTLAND, SCOTT D 3685 §101§112 Non-Final OA 79d overdue Pending Feb 12, 2024
18533699 COMPOSITION AND METHOD FOR PROLONG SURVIVAL OF TRANSPLANT AND RECIPIENT STEELE, AMBER D 1658 §101§103§112DP Non-Final OA — Pending Dec 08, 2023
18565862 PREPARATION AND STANDARDIZATION OF CELL SPHEROIDS FOR PROMOTING TISSUE REGENERATION BARRON, SEAN C 1653 §103 Final Rejection — Pending Nov 30, 2023
18015207 COMPOSITION FOR PREDICTING OR DIAGNOSING EARLY-STAGE DIFFUSE GASTRIC CANCER, COMPRISING PREPARATION FOR MEASURING LEVEL OF PEPSINOGEN II CLARKE, TRENT R 1651 §102§103 Final Rejection — Pending Oct 02, 2023
18553437 ANGIOGENESIS INHIBITING PEPTIDE AND USE THEREOF COFFA, SERGIO 1658 §102§112DP Non-Final OA — Pending Sep 29, 2023
18233783 METHOD FOR TREATING CANCER EXPRESSING SPARC NIEBAUER, RONALD T 1658 §103§112 Final Rejection 70d Pending Aug 14, 2023
18194781 METHODS FOR ISOLATING AND CULTURING LIVING CELLS USING METHOD OF PERMEABILIZING CELL MEMBRANE SCHUBERG, LAURA J 1631 §103 Final Rejection 13d Pending Apr 03, 2023
17926653 METHOD AND SYSTEM FOR PREDICTING NEEDS OF PATIENT FOR HOSPITAL RESOURCES JACKSON, JORDAN L 2857 §101 Final Rejection 9d Pending Mar 27, 2023
18024819 PEPTIDE, AND COSMETIC COMPOSITION AND PHARMACEUTICAL COMPOSITION COMPRISING SAME CHANDRA, GYAN 1674 §103 Final Rejection — Pending Mar 06, 2023

Managing Seoul National University Hospital's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month